1,720,969 research outputs found
Cholecystokinin (CCK)-B/gastrin-receptor binding peptides for diagnosis and therapy of metastatic medullary thyroid cancer.
No full textDoes external scintigraphy allow for predictions with respect to the toxicity and therapeutic efficacy of Herceptin (R) therapy of HER2/neu expressing breast cancer?
No full textRadiopeptide therapy with cholecysto-kinin (CCK)-B gastrin receptor ligands: Toxicity and therapeutic efficacy of auger E- versus alpha or beta emitters.
No full textDoes external scintigraphy allow for predictions with respect to the toxicity and therapeutic efficacy of Herceptin (R) therapy of HER2/neu expressing breast cancer?
No full textFactors influencing the dosimetry and the therapeutic outcome of I-131 therapy of differentiated thyroid cancer (DTC).
No full textHigh-dose radioimmunotherapy (RIT) of mantle cell lymphoma (MCL) with the I-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support.
No full textCholecystokinin (CCK)-B/gastrin-receptor binding peptides for diagnosis and therapy of metastatic medullary thyroid cancer.
No full textHigh-dose radioimmunotherapy (RIT) of mantle cell lymphoma (MCL) with the I-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support.
No full textRadiopeptide therapy with cholecysto-kinin (CCK)-B gastrin receptor ligands: Toxicity and therapeutic efficacy of auger E- versus alpha or beta emitters.
No full textFactors influencing the dosimetry and the therapeutic outcome of I-131 therapy of differentiated thyroid cancer (DTC).
No full text- …
